Skip to main content
Caplight Logo









Micronbrane Medical

Micronbrane Medical

Private
HsinchuHealthcare & Life Scienceshttps://micronbrane.com/

Last Round

Series A

Sep 1, 2022

Total Funding Raised

$4.5M

Company Overview

Micronbrane Medical is a biotechnology company that develops metagenomic next-generation sequencing (mNGS) solutions for rapid and accurate pathogen identification.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

metagenomic next-generation sequencingmNGSpathogen identificationhost DNA depletioninfectious disease diagnosticsbioinformatics pipelinesample preparationclinical diagnosticsNGS library preparationmicrobial enrichmentliquid biopsyprecision medicinediagnostic softwarewet-lab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Micronbrane Medical Comparables

Compare Micronbrane Medical with similar companies based on industry and business-model similarity.

Micronbrane Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Illumina, Inc.
76%
Cellectric Biosciences
76%
Zymo Research
74%

Micronbrane Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 1, 2022

Key People

Founding team and executive leadership

Mengchu Wu 吴梦楚

Co-Founder, CEO, Chairwoman of the Board

Founding Team

Micronbrane Medical Investors

Notable investors and investment history

Micronbrane Medical investors
InvestorRounds
CDIB Capital InternationalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 10, 2024

    Grew 25% QoQ, from 12 to 15 employees.

Micronbrane Medical Filings

Explore SEC and related filing metadata, where available.

Micronbrane Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Micronbrane Medical's valuation, stock price, and market status.

Is Micronbrane Medical a public or private company?

Micronbrane Medical is a private company.

What is the current stock price of Micronbrane Medical?

Micronbrane Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Micronbrane Medical worth (valuation)?

Valuation information for Micronbrane Medical is not publicly available.

Can I buy Micronbrane Medical stock?

Micronbrane Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Micronbrane Medical's last funding round?

Micronbrane Medical's most recent funding round was Series A on September 1, 2022.

Who are the main investors in Micronbrane Medical?

Key investors in Micronbrane Medical include CDIB Capital International.

Will Micronbrane Medical IPO soon?

No public IPO plans have been announced for Micronbrane Medical.

How can I track Micronbrane Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Micronbrane Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHsinchu
Employee Range12
Year Founded2020
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?